Generis and Ideagen Announce Integration to Advance Information Management Processes in Regulated Industries

LONDON - Dec. 13, 2023 - PRLog -- Generis, developer of the CARA Platform for data, content, and business process management, and Ideagen PleaseReview today announced their integration partnership to improve document management and review processes across regulated industries including life sciences and financial services.

"We're determined to make the lives of our customers as smooth as possible and believe this integration is a step in the right direction." Stuart Rowe, SVP of Collaboration commented. "A whole arm of Ideagen is about facilitating collaboration across teams and their stakeholders. So, by extension, we are delighted to collaborate and partner with Generis on the CARA Platform. Their ability to manage data and processes in a unified platform cuts out much of the frustrating day to day challenges businesses face. Together, they streamline secure yet simple document reviews and unify data management processes for all our customers."

Ideagen PleaseReview facilitates document owners and 2-200+ reviewers to spend less time chasing contributions, collating feedback and documenting changes. By enabling secure, real-time document reviews, co-authoring and redaction, Ideagen PleaseReview shortens the document review process by up to 65%. Users can delegate and control access as well as generate audit reports with one click, ensuring transparency and traceability across the review. The CARA Platform allows users to consolidate their complex regulated business processes, data and content on a single platform. Users can then create, locate and re-use information instantly - in any process across the organisation – leading to accelerated work, supported by more accurate information.

This integration allows users to streamline their workflow as part of the document review cycle. This allows clients to increase efficiency and security in their collaboration, reducing the scope for error without the additional difficulty in managing the integration themselves.

"Our partner ecosystem is a vital component of our customers' success,' commented James Kelleher, CEO of Generis. 'We've worked with Ideagen PleaseReview for many years making the arduous tasks of managing and reviewing documentation more intuitive and streamlined. This connector will allow customers to leverage the expertise and passion of both of our companies for better regulated processes."

About Ideagen

Headquartered in Nottingham UK, Ideagen brings clarity and confidence to the safe hands and trusted voices protecting our world.

We provide trusted, meaningful intelligence to regulated and high-compliance industries such as life sciences, healthcare, aviation, defence, finance, manufacturing and construction.

From the front line to the boardroom, our 11,400 customers include 15 of the top 20 global pharmaceutical companies, more than 250 global aviation organisations, nine of the top ten accounting firms, nine of the top ten global aerospace and defence corporations, and 65% of the top 20 global food & drink companies. More at ideagen.com.

About Generis

Generis is a UK-headquartered developer of world-class data, content and business process management for regulated industries globally. 60% of the top 20 life sciences companies rely on Generis' flagship CARA™ Life Sciences Platform, including AbbVie, UCB, Biogen, Reckitt, Bristol Myers Squibb, Bayer, Pfizer, and Merck KGaA. Today Generis serves more than 750,000 users worldwide, across use cases ranging from RIM, Regulatory / R&D and Safety use cases to Clinical, Non-clinical, Quality GxP, CMC, Pharmacovigilance, Medical Information / Medical Affairs applications and more. More at generiscorp.com.